Ottawa Hospital Research Institute

🇨🇦Canada

Country: 🇨🇦Canada

Ownership: Private

Established: 2001-01-01

Employees: 5K

Market Cap: -

Website: http://www.ohri.ca

Clinical Trials

Ozurdex Monotherapy Trial

Phase 4

Recruiting

Conditions: Uveitis, Posterior
Uveitis, Intermediate
Panuveitis

Interventions: Drug: Prednisone
Drug: Ozurdex 0.7mg Ophthalmic Implant

First Posted Date: 2021-11-01

Last Posted Date: 2024-04-05

Lead Sponsor: Ottawa Hospital Research Institute

Target Recruit Count: 84

Registration Number: NCT05101928

Locations: 🇨🇦
Ottawa Hospital Research Institute - Vision Research Centre, Ottawa, Ontario, Canada

REmote Cardiac MOnitoring of At-risk SYNCope Patients After Emergency Department Discharge -RCT

Not Applicable

Recruiting

Conditions: Syncope

Interventions: Device: Cardiophone Plus

First Posted Date: 2021-10-04

Last Posted Date: 2023-10-27

Lead Sponsor: Ottawa Hospital Research Institute

Target Recruit Count: 580

Registration Number: NCT05066347

Locations: 🇨🇦
The Ottawa Hospital - Civic and General Campuses, Ottawa, Ontario, Canada

Primary Thromboprophylaxis in Patients With Malignancy and Central Venous Catheters

Phase 3

Recruiting

Conditions: Cancer
Venous Thromboembolism

Interventions: Drug: Rivaroxaban 10 MG

First Posted Date: 2021-08-31

Last Posted Date: 2023-09-29

Lead Sponsor: Ottawa Hospital Research Institute

Target Recruit Count: 1828

Registration Number: NCT05029063

Locations: 🇨🇦
HHS - Juravinski Hospital, Hamilton, Ontario, Canada
🇨🇦
Sault Area Hospital, Sault Ste Marie, Ontario, Canada
🇨🇦
Ottawa Hospital Research Institute- The Ottawa Hospital, Ottawa, Ontario, Canada

and more 4 locations

SW-RCT Implementation of Canadian Syncope Risk Score Based Practice Recommendations

Not Applicable

Recruiting

Conditions: Syncope

Interventions: Other: Knowledge translation (KT) of the CSRS based practice recommendations

First Posted Date: 2021-07-22

Last Posted Date: 2024-03-25

Lead Sponsor: Ottawa Hospital Research Institute

Target Recruit Count: 14400

Registration Number: NCT04972071

Locations: 🇨🇦
Thunder Bay Regional Health Sicences Centre, Thunder Bay, Ontario, Canada
🇨🇦
Jewish General Hospital, Montréal, Quebec, Canada
🇨🇦
Hôpital de L'Enfant-Jésus, Québec, Quebec, Canada

and more 5 locations

Evaluating 6-months of HER2-targeted Therapy in Patients With HER2 Positive Early-stage Breast Cancer That Achieve a Pathological Complete Response to Neoadjuvant Systemic Therapy

Phase 4

Recruiting

Conditions: Breast Cancer

Interventions: Drug: Trastuzumab

First Posted Date: 2021-06-16

Last Posted Date: 2023-12-01

Lead Sponsor: Ottawa Hospital Research Institute

Target Recruit Count: 50

Registration Number: NCT04928261

Locations: 🇨🇦
The Ottawa Hospital Cancer Centre, Ottawa, Ontario, Canada

Evaluating Harms and Benefits of Endocrine Therapy in Patients ≥70 Years of Age With Lower Risk Breast Cancer

Phase 4

Active, not recruiting

Conditions: Breast Cancer

Interventions: Other: No endocrine therapy
Other: Endocrine therapy

First Posted Date: 2021-06-10

Last Posted Date: 2024-07-24

Lead Sponsor: Ottawa Hospital Research Institute

Target Recruit Count: 109

Registration Number: NCT04921137

Locations: 🇨🇦
The Ottawa Hospital, Ottawa, Ontario, Canada

Assessing the Mother-to-infant Transmission Capabilities of COVID-19 Infection Among Pregnant Women in Ontario, Canada

Completed

Conditions: SARS-CoV-2
Corona Virus Infection
Covid19
Pregnancy
Infectious Disease Transmission, Vertical

Interventions: Other: No intervention

First Posted Date: 2021-06-04

Last Posted Date: 2023-04-13

Lead Sponsor: Ottawa Hospital Research Institute

Target Recruit Count: 217

Registration Number: NCT04913948

Locations: 🇨🇦
The Ottawa Hospital - General Campus, Ottawa, Ontario, Canada
🇨🇦
Hamilton Health Sciences Corporation, Hamilton, Ontario, Canada
🇨🇦
Humber River Hospital, North York, Ontario, Canada

and more 9 locations

The Thoracic Peri-Operative Integrative Surgical Care Evaluation Trial - Stage II

Phase 3

Recruiting

Conditions: Esophageal Cancer
Lung Cancer
Gastric Cancer

Interventions: Dietary Supplement: Vitamin D3 Drops
Dietary Supplement: Coriolus Versicolor
Dietary Supplement: Probiotic Pro12
Dietary Supplement: Provitalix Pure Whey Protein
Dietary Supplement: Theracurmin 2X
Dietary Supplement: Green Tea Extract
Other: Nutrition Recommendations
Other: Physical Activity Recommendations
Behavioral: Psychological Recommendations

First Posted Date: 2021-05-04

Last Posted Date: 2023-05-09

Lead Sponsor: Ottawa Hospital Research Institute

Target Recruit Count: 20

Registration Number: NCT04871412

Locations: 🇨🇦
Michael Garron Hospital, Toronto, Ontario, Canada
🇨🇦
The Ottawa Hospital, Ottawa, Ontario, Canada

MYO-SHARE: MYO-MRI in Neuromuscular Diseases

Not yet recruiting

Conditions: Neuromuscular Diseases

First Posted Date: 2021-04-29

Last Posted Date: 2021-04-29

Lead Sponsor: Ottawa Hospital Research Institute

Target Recruit Count: 1000

Registration Number: NCT04866459

Locations: 🇨🇦
Ottawa Hospital Research Institute, Ottawa, Ontario, Canada

Venous Thrombosis Virtual Surveillance in COVID-19

Completed

Conditions: Venous Thromboembolism
Deep Vein Thrombosis
Pulmonary Embolism
Covid19

First Posted Date: 2021-04-29

Last Posted Date: 2023-03-24

Lead Sponsor: Ottawa Hospital Research Institute

Target Recruit Count: 510

Registration Number: NCT04865913

Locations: 🇨🇦
Ottawa Hospital Research Institute, Ottawa, Ontario, Canada

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy